ConductScience.org, home

Paper38149643

Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.

Wade R and 11 others. Health Technol Assess, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis. Papers, record 38149643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38149643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
PubMed
Journal
Health Technol Assess
PubMed
Year
2023
PubMed
Publication types
Journal Article, Systematic Review, Research Support, Non-U.S. Gov't, Network Meta-Analysis
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2025-06-23
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Ablation TechniquesMajor topic
Humans
Ethanol
Prospective Studies
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

References292

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128299619Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.J Gastrointest Surg2017https://conductscience.org/library/papers/28299619PubMed
225287439
Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox.
Ann Surg Oncol2015https://conductscience.org/library/papers/25287439PubMed
333708637Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes.Liver Cancer2021https://conductscience.org/library/papers/33708637PubMed
428983565The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.JAMA Oncol2017https://conductscience.org/library/papers/28983565PubMed
516004810[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma].Ai Zheng2005https://conductscience.org/library/papers/16004810PubMed
624863168Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas.Br J Surg2014https://conductscience.org/library/papers/24863168PubMed
716419155Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.World J Gastroenterol2005https://conductscience.org/library/papers/16419155PubMed
835116757Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients.Transl Cancer Res2019https://conductscience.org/library/papers/35116757PubMed
931774468Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/31774468PubMed
1031433531Factors related to the quality of life in liver cancer patients during treatment phase: A follow-up study.Eur J Cancer Care (Engl)2019https://conductscience.org/library/papers/31433531PubMed
1118823439Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.J Gastroenterol Hepatol2009https://conductscience.org/library/papers/18823439PubMed
1226984844Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma.J Zhejiang Univ Sci B2016https://conductscience.org/library/papers/26984844PubMed
1322157201Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.Radiology2012https://conductscience.org/library/papers/22157201PubMed
1430504537Surgical resection vs radiofrequency ablation in older adults with early stage hepatocellular carcinoma: Where do we stand?Saudi J Gastroenterol2018https://conductscience.org/library/papers/30504537PubMed
1524750429Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study.HPB (Oxford)2014https://conductscience.org/library/papers/24750429PubMed
1630449954Sensitivity of treatment recommendations to bias in network meta-analysis.J R Stat Soc Ser A Stat Soc2018https://conductscience.org/library/papers/30449954PubMed
1726893018Modified radiofrequency ablation for the treatment of hepatocellular carcinoma.Hepatol Res2016https://conductscience.org/library/papers/26893018PubMed
1826896371Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.Radiat Oncol2016https://conductscience.org/library/papers/26896371PubMed
1922095524Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.J Gastrointest Surg2012https://conductscience.org/library/papers/22095524PubMed
2033029483Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.Ann Surg Treat Res2020https://conductscience.org/library/papers/33029483PubMed

See all 292 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42794898Histotripsy Outcomes for Primary and Metastatic Hepatic Disease.Cancers (Basel)2026https://conductscience.org/library/papers/42794898PubMed
42273140Pharmacokinetics and anti-tumor efficacy of transarterial chemoembolization using small-particle lenvatinib-loaded beads in a rabbit VX2 liver tumor model.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42273140PubMed
42222382Constructing and validating a prognostic prediction nomogram model for hepatocellular carcinoma patients following high-intensity focused ultrasound treatment.Front Oncol2026https://conductscience.org/library/papers/42222382PubMed
41473256Protein Induced by Vitamin K Absence or Antagonist II in Primary Liver Cancer: Basic Research Insights and Clinical Applications.J Clin Transl Hepatol2025https://conductscience.org/library/papers/41473256PubMed
41010594Surgery Without Scalpel: Histotripsy as a Non-Invasive and Non-Thermal Modality for Liver Tumor Ablation.J Clin Med2025https://conductscience.org/library/papers/41010594PubMed
39851944Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration.Curr Oncol2025https://conductscience.org/library/papers/39851944PubMed
39041258LncRNA DERCNC in Hepatocellular Carcinoma with Cirrhosis Aggravates Tumor Proliferation by Targeting SOX9.Curr Cancer Drug Targets2025https://conductscience.org/library/papers/39041258PubMed
37902128The effectiveness of ablative and non-surgical therapies for early hepatocellular carcinoma: Systematic review and network meta-analysis of randomised controlled trials.Cancer Med2023https://conductscience.org/library/papers/37902128PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38149643

GET https://conductscience.org/api/papers/v1/38149643/references?page=2